DOI:
10.1055/s-00000129
Kardiologie up2date
LinksClose Window
References
Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K. et al.
Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.
Lancet 2002; 360: 196-202
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.